SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------- FORM 15 -------------------- Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-02516 PHARMACIA CORPORATION ------------------------------------------------------------------------------ (Exact name of registrant as specified in its charter) 100 Route 206 North Peapack, NJ 07977 (908) 901-8000 ------------------------------------------------------------------------------ (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, par value $2.00 per share Rights to Purchase Preferred Stock ------------------------------------------------------------------------------ (Title of each class of securities covered by this Form) None ------------------------------------------------------------------------------ (Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4 (a)(1)(i) [X ] Rule 12h-3 (b)(1)(ii) [ ] Rule 12g-4 (a)(1)(ii) [ ] Rule 12h-3 (b)(2)(i) [ ] Rule 12g-4 (a)(2)(i) [ ] Rule 12h-3 (b)(2)(ii) [ ] Rule 12g-4 (a)(2)(ii) [ ] Rule 15d-6 [ ] Rule 12h-3 (b)(1)(i) [X ] Approximate number of holders of record as of the certification or notice date: 1 Pursuant to the requirements of the Securities Exchange Act of 1934, Pharmacia Corporation, a Delaware corporation, by the undersigned duly authorized person. Dated: April 16, 2003 PHARMACIA CORPORATION By: /s/ Don W. Schmitz ------------------------------------ Name: Don W. Schmitz Title: Corporate Secretary